Genetic testing guides radiation doses in breast cancer trial
NCT ID NCT05528133
Summary
This study is testing whether genetic information from a patient's tumor can help doctors personalize radiation doses after breast cancer surgery. Researchers want to see if this approach improves cancer control while maintaining quality of life. The trial includes 86 people with triple negative breast cancer who have had breast-conserving surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact
Contact
-
Morton Plant Hospital - Baycare Health System
RECRUITINGClearwater, Florida, 33756, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.